Friday, March 19, 2010: 12:30 PM-2:00 PM
Grand Hall (Hyatt Regency Atlanta)
Poster
86
Real-time PCR Versus Traditional Culture Methods for the Identification of Staphylococcal Bacteremia and Its Effect on Antibiotic Administration
Christopher J. Bettacchi, MD, University of Alabama at Birmingham, Birmingham VA Medical Center;
Kinley Beck, University of Alabama School of Medicine;
John W. Baddley, MD, University of Alabama at Birmingham, Birmingham VA Medical Center;
Ken B. Waites, MD, University of Alabama at Birmingham, Birmingham VA Medical Center;
Mukesh Patel, MD, University of Alabama at Birmingham, Birmingham VA Medical Center
87
Procalcitonin as a marker to shorten antimicrobial treatment in septic patient in intensive care setting
Paula Rodrigues Sanches, Hospital Israelita Albert Einstein;
Rodrigo Octavio Deliberato, Hospital Israelita Albert Einstein;
Angela Tavares Paes, Hospital Israelita Albert Einstein;
Marines Dalla Valle Martino, Hospital Israelita Albert Einstein;
Carlos Eduardo dos Santos Ferreira, Hospital Israelita Albert Einstein;
Jacyr Pasternak, Hospital Israelita Albert Einstein;
Oscar Fernando Pavao dos Santos, Hospital Israelita Albert Einstein;
Alexandre R. Marra, MD, Hospital Israelita Albert Einstein
88
The ESAC-WebPPS application: Point Prevalence Surveys on Antimicrobial Prescribing Made Online
Arno Muller, Msc, PhD, University of Antwerp;
Nico Drapier, University of Antwerp;
Brice Amadeo, MSc, Inserm;
Peter Zarb, M.Phil, European Surveillance of Antimicrobial Consumption;
Béatrice Jans, Scientific Institute of Public Health;
Vanessa Vankerckhoven, Msc, PhD, University of Antwerp;
Peter Davey, Professor, Division of Community and Population Sciences and Education;
Herman Goossens, University of Antwerp
89
Hospitalizations with Healthcare-associated Complicated Skin and Skin Structure Infections: Inappropriate Empiric Therapy and Outcomes
Marya Zilberberg, MD, MPH, EviMed Research Group, LLC;
Andrew Shorr, MD, MPH, Washington Health Center;
Scott T. Micek, PharmD, Barnes Jewish Hospital;
Joyce Chen, MHS, MBA, Ortho-McNeil Janssen Scientific Affairs, LLC;
Andrew Ramsey, MPH, EviMed Research Group, LLC;
Alex Hoban, BA, Barnes Jewish Hospital;
Victor Pham, BA, Barnes Jewish Hospital;
Joshua A. Doherty, BS, Washington University School of Medicine;
Samir H. Mody, PharmD, MBA, Ortho-McNeil Janssen Scientific Affairs, LLC;
Marin Kollef, MD, Barnes Jewish Hospital
91
A methodology for a Point Prevalence Survey on antimicrobial prescriptions in a network of high skilled nursing homes in Europe, European Surveillance of Antimicrobial Consumption (ESAC), 2009
Beatrice Jans, MHospSci, Scientific Institute of Public Health;
Arno Muller, PhD, University of Antwerp;
Nico Drapier, University of Antwerp;
Vanessa Vankerckhoven, PhD, University of Antwerp;
Katrien Latour, MSc, Scientific Institute of Public Health;
Ellen Broex, MSc, Scientific Institute of Public Health;
Rudi Stroobants, MD, University of Antwerp;
Herman Goossens, PhD, University of Antwerp
92
Advocating Institutional Funding for a Pediatric Antimicrobial Stewardship Program: The Value of a Formal Analysis
Emily A. Thorell, MD, University of Utah-Division of Pediatric Infectious Disease;
Jared A. Olson, PharmD, Primary Children's Medical Center;
E. Kent Korgenski, MS, Intermountain Healthcare, Pediatric Clinical Program;
Jared Cash, PharmD, Primary Children's Medical Center;
Jeanne DePaulis, RN, MBA, Primary Children's Medical Center;
Katy Welkie, BSN, MBA, Primary Children's Medical Center;
Howard B. Parker, PhD, Primary Children's Medical Center;
Andrew T. Pavia, MD, University of Utah-Division of Pediatric Infectious Disease
93
Improving Antimicrobial Stewardship Programs: a National Survey of the IDSA Emerging Infections Network
Susan E. Beekmann, RN, MPH, University of Iowa;
Birgir Johannsson, MD, University of Iowa;
Adam L. Hersh, MD, PhD, University of California, San Francisco;
Philip Polgreen, MD, MPH, University of Iowa
97
Back-end approach antimicrobial stewardship program in a cardiology center in Brazil – the pharmacist role
Rodrigo Pires dos dos Santos, MD, PhD, Instituto de Cardiologia, Fundação Faculdade de Cardiologia;
Lucas Magedanz, Instituto de Cardiologia, Fundação Faculdade de Cardiologia;
Erci Silliprandi, Instituto de Cardiologia, Fundação Faculdade de Cardiologia;
Thalita Jacoby, Hospital de Clínicas de Porto Alegre;
Juliana Guedes, Instituto de Cardiologia, Fundação Faculdade de Cardiologia;
Anderlise Luvizetto, Instituto de Cardiologia, Fundação Faculdade de Cardiologia
98
Survey of Antimicrobial Stewardship Practices
Lauren D. Nadkarni, BS, Tufts Medical Center;
Kenneth R. Lawrence, PharmD, Tufts Medical Center;
Lisa Davidson, MD, MS, Tufts Medical Center;
Caren Garber, Tufts Medical Center;
David R. Snydman, MD, FACP, Tufts Medical Center;
Jack Evans, RPh, MS, MBA, Yankee Alliance;
Shira I. Doron, MD, MS, Tufts Medical Center
100
A Multifaceted Intervention to Decrease Inappropriate Piperacillin and Tazobactam Use and Its Effects on Cefepime Utilization and Hospital-Acquired Clostridium Difficile Associated Diarrhea Rates
Dmitry Kiyatkin, M.D., Johns Hopkins Bayview Medical Center, Johns Hopkins School of Medicine;
Gina L. Bazemore, Pharm.D., Johns Hopkins Bayview Medical Center, Johns Hopkins School of Medicine;
Jonathan M. Zenilman, M.D., Johns Hopkins Bayview Medical Center, Johns Hopkins School of Medicine;
Catherine L. Passaretti, M.D., Johns Hopkins Bayview Medical Center, Johns Hopkins School of Medicine
101
A Comparison of Unnecessary Antibiotic Use Associated with a Two-step Algorithm for Detection of Clostridium difficile Infection (CDI) Using Either Cell Culture Cytotoxicy Neutralization Assay (CCNA) or PCR Toxin Gene Detection (PCR) Confirmatory Tests
Abigail A. Lenhart, MD, Johns Hopkins Hospital;
Brandon Trollinger, Pharm, D, Johns Hopkins Hospital;
Kentra Tillman, Johns Hopkins Hospital;
Edina Avdic, Pharm, D, MBA, Johns Hopkins Hospital;
Karen C. Carroll, MD, Johns Hopkins Hospital;
Lisa L. Maragakis, MD, MS, Johns Hopkins Hospital;
Sara E. Cosgrove, MD, MS, Johns Hopkins Hospital
102
Fluoroquinolone Use in an Urban Community Teaching Hospital: an Interventional Quality Assurance Study
Rohit Sharma, MD, LUTHERAN MEDICAL CENTER;
Khalil Al-Nassir, MD, LUTHERAN MEDICAL CENTER;
Afaf Pouls, MD, LUTHERAN MEDICAL CENTER;
Ram Krishna Mukkara Siva, MD, LUTHERAN MEDICAL CENTER;
Nadeem Shahid, MD, LUTHERAN MEDICAL CENTER;
Surinder P. Singh, MD, LUTHERAN MEDICAL CENTER;
Taleb Taha, MD, LUTHERAN MEDICAL CENTER;
David Tompkins, MD, LUTHERAN MEDICAL CENTER;
Kell Julliard, MA, LUTHERAN MEDICAL CENTER;
Ernest Visconti, MD, LUTHERAN MEDICAL CENTER
103
Inappropriate Use of Antimicrobials at an Academic Medical Center
Manish M. Tiwari, MBBS, PhD, MPH, University of Nebraska Medical Center;
Mark E. Rupp, MD, University of Nebraska Medical Center;
Mary E. Charlton, PhD, University of Nebraska Medical Center;
Elizabeth D. Hermsen, PharmD, MBA, The Nebraska Medical Center
104
Antimicrobial Approval Program and Impact on Antimicrobial Prescription, Antimicrobial Resistance, and Mortality in a Tertiary-Care Teaching Hospital in Thailand: a Preliminary Study
Romanee Chaiwarith, MD, MHS, Division of Infectious Diseases, Department of Medicine, Faculty of Medicine, Chiang Mai University;
Kaweesak Chittawatanarat, MD, Department of Surgery, Faculty of Medicine, Chiang Mai University;
Nontakarn Nuntachit, MD, Division of Infectious Diseases, Department of Medicine, Faculty of Medicine, Chiang Mai University;
Parichat Salee, MD, Division of Infectious Diseases, Department of Medicine, Faculty of Medicine, Chiang Mai University;
Khuanchai Supparatpinyo, MD, Division of Infectious Diseases, Department of Medicine, Faculty of Medicine, Chiang Mai University;
Peninnah Oberdorfer, MD, PhD, Division of Infectious Diseases, Department of Pediatrics, Faculty of Medicine, Chiang Mai University
105
Antibiotic Use in Hospitals: Results from a Surveillance Network in 530 French Hospitals, 2007
Catherine Dumartin, PharmD, Southwest nosocomial infection control coordinating center (CCLIN Sud-Ouest);
François L'Hériteau, MD, CCLIN Paris-Nord;
Muriel Péfau, Southwest nosocomial infection control coordinating center (CCLIN Sud-Ouest);
Xavier Bertrand, PhD, CCLIN Est;
Pascal Jarno, MD, CCLIN Ouest;
Sandrine Boussat, MD, CCLIN Est;
Pacome Angora, CCLIN Ouest;
Karine Saby, CCLIN Est;
Ludivine Lacavé, CCLIN Paris-Nord;
Anne Savey, MD, CCLIN Sud-Est;
Florence Nguyen, CCLIN Sud-Est;
Anne Carbonne, MD, CCLIN Paris-Nord;
Anne-Marie Rogues, PhD, Southwest nosocomial infection control coordinating center (CCLIN Sud-Ouest)
106
Evaluation of Faculty and Resident Physicians' Knowledge and Perceptions about Antimicrobial Use and Resistance: A Web Based Survey
Lilian Abbo, MD, University of Miami;
Ronda Sinkowitz-Cochran, MPH, Centers for Disease Control and Prevention;
Orlando Gómez-Marín, PhD, University of Miami;
Ella Ariza-Heredia, MD, University of Miami;
Laura Smith, PharmD, Jackson Memorial Hospital;
Arjun Srinivasan, MD, CDC;
Thomas M. Hooton, MD, University of Miami
111
Antimicrobial Stewardship in Australia
Marilyn Cruickshank, Australian Commission on Safety and Quality in Health Care;
Margaret Duguid, Australian Commission on Safety and Quality in Health Care;
Graham Bedford, Australian Commission on Safety and Quality in Health Care
112
Electronic antibiotic stewardship in a tertiary cancer centre
Karin Thursky, MBBS, MD, Peter MacCallum Cancer Centre;
Verna Wallroth, BPharm, Peter MacCallum Cancer Centre;
Sue Kirsa, BPharm, Peter MacCallum Cancer Centre;
Adrian Tramontana, Peter MacCallum Cancer Centre;
Kirsty L. Buising, MBBS, MD, MPH, Victorian infectious diseases service royal melbourne hospital;
Monica Slavin, MBBS, MD, Peter MacCallum Cancer Centre
113
Frequency of Accurate Vancomycin Monitoring for Adult Patients in an Acute Tertiary Care Hospital: Implications for Patient Care
Prasanthi Jasty, MD, Drexel University College of Medicine;
Diana Mercado, MD, Drexel University College of Medicine;
Radhika Polisetty, Pharm, D, Hahnemann University Hospital;
Ole Vielemeyer, MD, Drexel University College of Medicine;
Dong Heun Lee, Drexel University College of Medicine
114
Impact of a Antimicrobial Stewardship Program at the University of Minnesota Medical Center
Susan Kline, MD., MPH, University of Minnesota;
Kim Boeser, Pharm, D, University of Minnesota Medical Center,Fairview;
Pam Phelps, Pharm, D, University of Minnesota Medical Center,Fairview;
Christine E. Hendrickson, RN, BSHA, University of Minnesota Medical Center, Fairview;
Anita Guelcher, RN, University of Minnesota Medical Center, Fairview;
Peggy Bonnell, RN, University of Minnesota Medical Center, Fairview
116
Targets for Antibiotic and Institutional Resource Stewardship in Inpatient Community-Acquired Pneumonia
Timothy C. Jenkins, MD, Denver Health Medical Center and University of Colorado Denver;
Lilia Cervantes, MD, Denver Health Medical Center and University of Colorado Denver;
Sarah A. Stella, MD, Denver Health Medical Center and University of Colorado Denver;
Angela Keniston, MSPH, Denver Health Medical Center;
Allison L. Sabel, MD, PhD, MPH, Denver Health Medical Center and University of Colorado Denver;
Connie S. Price, MD, Denver Health Medical Center and University of Colorado Denver;
William J. Burman, MD, Denver Health Medical Center and University of Colorado Denver;
Philip S. Mehler, MD, Denver Health Medical Center and University of Colorado Denver
119
Comparative Aggregate and Class-Specific Antimicrobial Utilization in 13 Intensive Care Units from 4 Teaching Hospitals: Results of the CDC Prevention Epicenters Antimicrobial Use Study Group
David Schwartz, MD, Stroger Hospital Of Cook County;
R. Scott Evans, Ms, PhD, FACMI, University of Utah;
Bernard Camins, MD, Washington University School of Medicine;
Yosef Khan, MBBS, MPH, The Ohio State University Medical Center;
Kurt Stevenson, MD, Ohio State Medical Center;
James F. Lloyd, BS, University of Utah;
Julie L. Freshwater, BA, MPH, The Ohio State University Medical Center
121
Successful Antimicrobial Stewardship Program at a Teaching Hospital
Madiha Mushtaq, PharmD, Riverside County Regional Medical Center;
Madé Sutjita, MD, Riverside County Regional Medical Center;
Li Chengqing, PharmD, Riverside County Regional Medical Center;
Christopher L. Johnson, Riverside County Regional Medical Center;
Lee Klevens, PharmD, Riverside County Regional Medical Center;
Arnold Tabuenca, MD, Riverside County Regional Medical Center;
Silvia I. Gnass, Riverside County Regional Medical Center
122
The Impact of a Proactive Computerized Physician Order Entry Antibiotic Stewardship Program (CPOE-ASP) on Tigecycline and Linezolid Use in a Community Hospital
John Leander Po, MSc, MD, PhD, Banner Estrella Medical Center;
Jackie L. Dix, PharmD, BCPS, Banner Estrella Medical Center;
Bao Nguyen, PharmD, BCPS, Banner Estrella Medical Center;
Mary Martin, PharmD, Banner Estrella Medical Center
![[ Visit the Fifth Decennial online ]](images/banner.gif)